Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$540K Buy
1,490
+5
+0.3% +$1.71K 0.2% 37
2026
Q1
$522K Sell
1,485
-294
-17% -$105K 0.23% 36
2025
Q4
$582K Buy
1,779
+490
+38% +$155K 0.26% 37
2025
Q3
$364K Buy
1,289
+15
+1% +$4.35K 0.17% 44
2025
Q2
$356K Sell
1,274
-13
-1% -$3.68K 0.16% 40
2025
Q1
$401K Buy
1,287
+5
+0.4% +$1.48K 0.26% 31
2024
Q4
$334K Buy
+1,282
New +$380K 0.22% 34

Other funds holding AMGN

Kilter Group's AMGN Position: Q2 2026 in Review

Kilter Group increased its Amgen (AMGN) stake by 0.34% in Q2 2026, buying an estimated $1.71K and bringing the position to 1,490 shares worth $540K. The position accounts for 0.2% of the portfolio, ranked #37.

Kilter Group first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. The position peaked at $582K in Q4 2025. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Kilter Group held 1,490 shares of Amgen worth $540K as of Q2 2026.
  • Kilter Group bought 5 Amgen shares in Q2 2026, an estimated $1.71K.
  • Amgen made up 0.2% of Kilter Group's portfolio in Q2 2026, its #37 holding.
  • Kilter Group first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • Kilter Group's Amgen position peaked at $582K in Q4 2025.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Kilter Group's 13F filing for Q2 2026, filed 11 Aug 2026.